TERA Foundation has proposed and designed hadrontherapy facilities based on novel linacs, i.e. high gradient linacs which accelerate either protons or light ions. The overall length of the linac, and therefore its cost, is almost inversely proportional to the average accelerating gradient. With the scope of studying the limiting factors for high gradient operation and to optimize the linac design, TERA, in collaboration with the CLIC Structure Development Group, has conducted a series of high gradient experiments. The main goals were to study the high gradient behavior and to evaluate the maximum gradient reached in 3 and 5.7 GHz structures to direct the design of medical accelerators based on high gradient linacs. This paper summarizes the...
In the last years, many developments have contributed to make feasible an all linac solution for pro...
Proton and carbon ion beams present advantageous depth-dose distributions with respect to ...
Compact and more affordable, facilities for proton therapy are now entering the market of commercial...
Compact, reliable and little consuming accelerators are required for the treatment of tumours with i...
Accelerating gradients in excess of 100 MV/m are essential for future multi-TeV linear colliders in ...
International audienceThe high-gradient performance of an accelerating structure prototype for a med...
International audienceThe high-gradient performance of an accelerating structure prototype for a med...
Accelerating gradients in excess of 100 MV/m are essential for future multi-TeV linear colliders in ...
Accelerating gradients in excess of 100 MV/m are essential for future multi-TeV linear colliders in ...
A novel high-gradient accelerating structure with low phase velocity, v/c=0.38, has been designed, m...
International audienceThere is growing demand from the industrial and research communities for high ...
International audienceThere is growing demand from the industrial and research communities for high ...
International audienceThere is growing demand from the industrial and research communities for high ...
International audienceThere is growing demand from the industrial and research communities for high ...
Proton therapy is a rapidly developing technique for tumour treatment, thanks to the physical and do...
In the last years, many developments have contributed to make feasible an all linac solution for pro...
Proton and carbon ion beams present advantageous depth-dose distributions with respect to ...
Compact and more affordable, facilities for proton therapy are now entering the market of commercial...
Compact, reliable and little consuming accelerators are required for the treatment of tumours with i...
Accelerating gradients in excess of 100 MV/m are essential for future multi-TeV linear colliders in ...
International audienceThe high-gradient performance of an accelerating structure prototype for a med...
International audienceThe high-gradient performance of an accelerating structure prototype for a med...
Accelerating gradients in excess of 100 MV/m are essential for future multi-TeV linear colliders in ...
Accelerating gradients in excess of 100 MV/m are essential for future multi-TeV linear colliders in ...
A novel high-gradient accelerating structure with low phase velocity, v/c=0.38, has been designed, m...
International audienceThere is growing demand from the industrial and research communities for high ...
International audienceThere is growing demand from the industrial and research communities for high ...
International audienceThere is growing demand from the industrial and research communities for high ...
International audienceThere is growing demand from the industrial and research communities for high ...
Proton therapy is a rapidly developing technique for tumour treatment, thanks to the physical and do...
In the last years, many developments have contributed to make feasible an all linac solution for pro...
Proton and carbon ion beams present advantageous depth-dose distributions with respect to ...
Compact and more affordable, facilities for proton therapy are now entering the market of commercial...